Oral supplements as adjunctive treatment to nutritional counseling in malnourished HIV-infected patients: Randomized controlled trial

Clinical Nutrition

Volumn 18, Issue 6, 1999, Pages 371-374

  Schwenk, A ^a,b   Steuck, H ^a   Kremer, G ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Acquired immunodeficiency syndrome; Counseling; Dietary supplements; HIV wasting syndrome; Nutritional support; Randomized controlled trial

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; NUTRITIONAL SUPPORT; PATIENT COUNSELING; RANDOMIZED CONTROLLED TRIAL; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 0033401884     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0261-5614(99)80018-1     Document Type: Article

References (24)

1. Schwenk A. HIV infection and malnutrition. Curr Opin Clin Nutr Metab Care 1998; 1: 375-380
2. Fätkenheuer G, Theisen A, Rockstroh J et al. Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients. AIDS 1997; 11: F113-116
3. Macallan D C, Noble C, Baldwin C et al. Energy expenditure and Wasting in Human Immunodeficiency Virus Infection. New Engl J Med 1995; 333: 83-88
4. Sharpstone D R, Ross H M, Gazzard B G. The metabolic response to opportunistic infections in AIDS. AIDS 1996; 10: 1529-1533
5. Babameto G, Kotler D P. Malnutrition in HIV infection. Gastroenterol Clin North Am 1997; 26(2): 393-415
6. American Gastroenterological Association medical position Statement: guidelines for the management of malnutrition and cachexia, chronic diarrhea, and hepatobiliary disease in patients with human immunodeficiency virus infection. Gastroenterology 1996; 111: 1722-1723
7. Chlebowski R T, Beall G, Grosvenor M et al. Long-term effects of early nutritional support with new enterotropic peptide-based formula vs standard enteral formula in HIV-infected patients: randomized prospective trial. Nutrition 1993; 9: 507-512
8. Pichard C, Sudre P, Karsegard V et al. A randomized double-blind controlled study of 6 months of oral nutritional supplementation with arginine and Omega-3 fatty acids in HIV-infected patients. AIDS 1998; 12: 53-63
9. Rabeneck L, Palmer A, Knowles J B et al. A randomized controlled trial evaluating nutrition counseling with or without oral supplementation in malnourished HIV-infected patients. J Am Diet Assoc 1998; 98: 434-438
10. Bürger B, Schwenk A, Jünger H, Ollenschläger G, Wessel D, Diehl V, Schrappe M. Oral supplements in HIV-infected patients with chronic wasting - a prospective trial. Medizinische Klinik 1994; 89: 579-581
11. Report of the NIH Panel to Define Principles of Therapy of HIV Infection and Guidelines for the Use of Antiretroviral Agents in HIV-infected Adults and Adolescents. MMWR 1998; 47: 43-83
12. Data Input. NUTRI4 Handbook. Frankfurt: Data Input, 1997
13. Dunbar C, Melahrinides E, Michielli D, Kalinski M. Effects of small errors in electrode placement on body composition assessment by bioelectrical impedance. Res Q Exerc Sport 1994; 65: 291-294
14. Kotler D P, Burastero S, Wang J, Pierson R N. Prediction of body cell mass, fat-free mass, and total body water with bioelectrical impedance analysis: effects of race, sex, and disease. Am J Clin Nutr 1996; 64: 489S-497S
15. Briefel R R, Sempos C T, McDowell M A, Chien S, Alaimo K. Dietary methods research in the third National Health and Nutrition Examination Survey: underreporting of energy intake. Am J Clin Nutr 1997;65: 1203S-1209S
16. Schwenk A, Kremer G. Ernährungsberatung. In: Jäger H, ed. Wasting und AIDS - Die Behandlung der HIV-bedingten Kachexie. Stuttgart: Thieme, 1997: 71-80
17. Norusis M J. SPSS Advanced Statistics 7.0 Update. Chicago: SPSS Inc., 1996
18. Bauer P, Köhne K. Evaluation of experiments with adaptive interim analyses. Biometrics 1994; 50: 1029-1041
19. Schwenk A, Kremer G, Comely O, Diehl V, Salzberger B, Fätkenheuer G. Body weight changes with protease inhibitor treatment of HIV infection. Nutrition 1999; 15: 453-457
20. Carr A, Samaras K, Burton S. A syndrome of peripheral lipodystrophy, hyperlipidemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998; 12: F51-F58
21. Miller K D, Jones E, Yanovski J A, Shankar R, Feuerstein I, Falloon J. Visceral abdominal-fat accumulation associated with use of indinavir. Lancet 1998; 351: 871-875
22. Moore F D, Oleson K H, McMurray J D, Parker H V, Boyden C M. The body cell mass and its supporting environment: body composition in health and disease. Philadelphia: W.B. Saunders, 1963
23. Schambelan M, Mulligan K, Grunfeld C et al. Recombinant human growth hormone in patients with HIV-associated wasting - a randomized, placebo-controlled trial. Ann Intern Med 1996; 125: 873-882
24. Paton N I, Elia M, Jennings G, Ward L C, Griffin G E. Bioelectrical impedance analysis in Human Immunodeficiency Virus - infected patients: comparison of single frequency with multifrequency, spectroscopy and other novel approaches. Nutrition 1998; 14: 658-666